Lv2
188 积分 2025-04-02 加入
The Affinity Advantage
1个月前
已完结
Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis
2个月前
已完结
Identification and Validation of PKR as a Direct Target for the Novel Sulfonamide-Substituted Tetrahydroquinoline Nonselective Inhibitor of the NLRP3 Inflammasome
2个月前
已完结
Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis
2个月前
已完结
Discovery of a Potent and Selective Targeted NSD2 Degrader for the Reduction of H3K36me2
3个月前
已完结
Drug Discovery Targeting Nuclear Receptor Binding SET Domain Protein 2 (NSD2)
3个月前
已完结
Asymmetric synthesis and biological evaluation of imidazole- and oxazole-containing synthetic lipoxin A4 mimetics (sLXms)
3个月前
已完结
Convergent Solutions to Binding at a Protein-Protein Interface
3个月前
已完结
Impact of Dynamically Exposed Polarity on Permeability and Solubility of Chameleonic Drugs Beyond the Rule of 5
3个月前
已完结
Prediction of Chameleonic Efficiency
3个月前
已完结
皖公网安备34019202002308
